Acute and long-term effects of the 5-HT2 receptor antagonist ritanserin on EEG power spectra, motor activity, and sleep: changes at the light–dark phase shift
- 23 April 2002
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 943 (1) , 105-111
- https://doi.org/10.1016/s0006-8993(02)02698-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 8-OH-DPAT and MK-801 affect epileptic activity independently of vigilanceNeurochemistry International, 2001
- Differential EEG effects of the anxiolytic drugs, deramciclane (EGIS-3886), ritanserin and chlordiazepoxide in ratsPsychopharmacology, 1999
- RS-102221: A Novel High Affinity and Selective, 5-HT2C Receptor AntagonistPublished by Elsevier ,1998
- Detection of seven sleep-waking stages in the ratNeuroscience & Biobehavioral Reviews, 1992
- Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleepsstages and EEG power spectraEuropean Journal of Pharmacology, 1989
- The light-dark cycle modulates the effects of ritanserin on sleep-wakefulness patterns in the ratPharmacology Biochemistry and Behavior, 1989
- Effect of ritanserin on sleep stages and sleep EEG in the ratEuropean Journal of Pharmacology, 1988
- Nucleus basalis and thalamic control of neocortical activity in the freely moving ratJournal of Neuroscience, 1988
- 5-HT2 receptors could be primarily involved in the regulation of slow-wabe sleep in the ratEuropean Journal of Pharmacology, 1987
- 5-Hydroxytryptamine-2 antagonist increases human slow wave sleepBrain Research, 1986